These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 29777282

  • 1. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
    Apostolopoulou SC, Vagenakis GA, Tsoutsinos A, Kakava F, Rammos S.
    Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
    Sindone AP, Keogh AM, Macdonald PS, McCosker CJ, Kaan AF.
    Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101
    [Abstract] [Full Text] [Related]

  • 6. Long-term intravenous inotropes in low-output terminal heart failure?
    von Scheidt W, Pauschinger M, Ertl G.
    Clin Res Cardiol; 2016 Jun; 105(6):471-81. PubMed ID: 26879807
    [Abstract] [Full Text] [Related]

  • 7. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC.
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS.
    Am J Cardiol; 2007 Jul 01; 100(1):90-3. PubMed ID: 17599447
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol.
    Hastenteufel LCT, Clausell N, Neyeloff JL, Domingues FB, Caballero LG, Silva ERRD, Goldraich LA.
    Arq Bras Cardiol; 2019 Jun 06; 112(5):573-576. PubMed ID: 31188963
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure.
    Bonios MJ, Terrovitis JV, Drakos SG, Katsaros F, Pantsios C, Nanas SN, Kanakakis J, Alexopoulos G, Toumanidis S, Anastasiou-Nana M, Nanas JN.
    Int J Cardiol; 2012 Sep 06; 159(3):225-9. PubMed ID: 21481958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.